CYTOMED THERAPEUTICS LIMITED

Highlights CytoMed Therapeutics Limited

Equities

GDTC

SGXZ17669631

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-23 EDT			5-day change	1st Jan Change
2.02 ^USD	-1.94%		-5.16%	-58.78%

04-22	CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-14	Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
CytoMed Therapeutics Limited to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies	03-18	CI
CytoMed Therapeutics Limited Announces Research Collaboration with Sengkang General Hospital Pte Ltd to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair	03-04	CI
CytoMed Therapeutics Receives Patent in Malaysia for its Prospective Cancer Therapy	01-29	MT
CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2023	11-17	CI
CytoMed Therapeutics Limited Announces Entering into A Memorandum of Understanding with CNK Therapeutics Co., Ltd	23-08-29	CI
CytoMed Therapeutics Announces China Research Collaboration to Enhance Allogeneic CAR ?d T In Vivo Persistency	23-08-15	CI
CytoMed Therapeutics Granted US Patent for its Licensed CAR-Gamma Delta T Cell Technology	23-07-06	MT
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-The-Shelf Gamma Delta T Cells in Oncology	23-05-09	CI
CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI
CytoMed Closes $9.65 Million Initial Public Offering	23-04-18	MT
CytoMed Therapeutic Shares Fall in Nasdaq Debut	23-04-14	MT
CytoMed Therapeutics Prices IPO at $4 per Share	23-04-14	MT
CytoMed Therapeutics Limited has completed an IPO in the amount of $9.649476 million.	23-04-13	CI
CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2022	23-02-01	CI
CytoMed Therapeutics Limited has filed an IPO in the amount of $15 million.	22-11-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer